Lipid metabolic reprogramming of CD8+ T cells in the tumor microenvironment
Cellular Signalling · 2026-07 · 143 · 112496
DOI: 10.1016/j.cellsig.2026.112496 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-07. Verfasst von Lujing Mao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, CD8-Positive T-Lymphocytes, Lipid Metabolism, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Metabolic reprogramming within the tumor microenvironment is a critical driver of CD8+ T cell dysfunction that limits the efficacy of cancer immunotherapy. While glucose and amino acid deprivation are well-characterized, lipid metabolic rewiring has emerged as a fundamental determinant of T cell fate. This review systematically examines the mechanisms by which the tumor microenvironment disrupts CD8+ T cell lipid metabolism to promote functional exhaustion and ferroptosis. We first discuss how local stressors such as hypoxia and acidosis alongside systemic host factors including obesity and hyperlipidemia synergistically impose a metabolic siege on infiltrating T cells. We then detail the molecular pathways of dysregulation revealed by recent lipidomic profiling, including CD36-mediated uptake of oxidized lipids that drives ferroptosis, as well as the dysregulation of cholesterol homeostasis that impairs TCR signaling and induces endoplasmic reticulum stress via the IRE1α-XBP1 axis, which directly drives the transcriptional expression of immune checkpoints. Finally, we evaluate therapeutic strategies such as pharmacological modulation of lipid transporters and metabolic engineering of CAR-T cells which hold promise for restoring metabolic fitness and reinvigorating antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Histology and Embryology, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, Hunan, China.
- Department of Obstetrics, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Tumor ImmunoMetabolism Institute (TIMI), The affiliated Zhuzhou hospital Xiangya medical college, Central South University, Zhuzhou, Hunan, China. Electronic address: yukun_li@csu.edu.cn.
- Department of Histology and Embryology, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Electronic address: wudaichao@usc.edu.cn.
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Mao, L., Zou, J., Jin, H., Liao, W., Li, Y., & Wu, D. (2026). Lipid metabolic reprogramming of CD8+ T cells in the tumor microenvironment. Cellular Signalling, 143, 112496. https://doi.org/10.1016/j.cellsig.2026.112496
Vancouver
Mao L, Zou J, Jin H, Liao W, Li Y, Wu D. Lipid metabolic reprogramming of CD8+ T cells in the tumor microenvironment. Cellular Signalling. 2026;143:112496. doi:10.1016/j.cellsig.2026.112496
BibTeX
@article{Mao2026,
author = {Mao, Lujing and Zou, Juan and Jin, Huimin and Liao, Wenyan and Li, Yukun and Wu, Daichao},
title = {Lipid metabolic reprogramming of CD8+ T cells in the tumor microenvironment},
journal = {Cellular Signalling},
year = {2026},
volume = {143},
pages = {112496},
doi = {10.1016/j.cellsig.2026.112496}
}
EUVIMED